Quazepam
These highlights do not include all the information needed to use QUAZEPAM TABLETS safely and effectively. See full prescribing information for QUAZEPAM TABLETS. QUAZEPAM TABLETS for oral use C-IV Initial U.S. Approval: 1985
Approved
Approval ID
f7d63f3f-5303-48ab-bce2-35fd62c45799
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 22, 2023
Manufacturers
FDA
Atland Pharmaceuticals, LLC
DUNS: 080942150
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Quazepam
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code71993-265
Application NumberNDA018708
Product Classification
M
Marketing Category
C73605
G
Generic Name
Quazepam
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 22, 2023
FDA Product Classification
INGREDIENTS (8)
POWDERED CELLULOSEInactive
Code: SMD1X3XO9M
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
LACTOSEInactive
Code: J2B2A4N98G
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
QUAZEPAMActive
Quantity: 15 mg in 1 1
Code: JF8V0828ZI
Classification: ACTIB